Status:
COMPLETED
Radiogenomics in Aerodigestive Tract Cancers
Lead Sponsor:
Buddhist Tzu Chi General Hospital
Conditions:
Cancer, Lung
Cancer of Esophagus
Eligibility:
All Genders
20+ years
Brief Summary
Aerodigestive tract cancers are common malignancies. These cancers were ranked to be top-ten cancer-related deaths in Taiwan. Although many new target therapies and immunotherapies have emerged, many ...
Detailed Description
This is a prospective study and The investigators use the routine pathological specimens for next generation sequencing (NGS), microsatellite instability (MSI) and immunohistochemical stains. Patholo...
Eligibility Criteria
Inclusion
- Age at least 20-years
- Pathological proven aerodigestive tract cancers and received complete staging work-up
- Pathological specimen of the primary tumor
- The solid part of the primary tumor should be at least 2 cm for the lung or head and neck cancers. The primary tumor of the esophageal cancer should be at least cT2.
Exclusion
- Coexistence of non-aerodigestive tract cancer.
- Only receive best supportive care after diagnosis.
- Unable to comply to FDG PET/CT exam.
- Unable to determine the primary tumor.
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT04314349
Start Date
August 1 2020
End Date
December 31 2023
Last Update
March 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hualien Tzu Chi Hospital
Hualien City, Taiwan, 970